Advertisement
Screener

PALISADE BIO, INC. (PALI) Shares Authorized

2.8 / 5 stars · 68/120 Roast Me

PALISADE BIO, INC. Shares Authorized

PALISADE BIO, INC. (PALI) had Shares Authorized of 450.00 million shares as of 2026-06-30, per its 10-Q filed 2026-08-10.

Financial Statements › Balance Sheet › Equity › Common Stock, Number of Shares, Par Value and Other Disclosure

us-gaap:CommonStockSharesAuthorized · last filed 2026-08-10

  • 2026-06-30: Common Stock, Shares Authorized 450.00M shares.
  • 2026-06-10: Common Stock, Shares Authorized 450.00M shares.
  • 2026-03-31: Common Stock, Shares Authorized 300.00M shares.
  • 2025-12-31: Common Stock, Shares Authorized 300.00M shares.
Period endCommon Stock, Shares AuthorizedCommon Stock, Shares Authorized as first filed
2026-06-30450.00M shares
10-Q · filed 2026-08-10
2026-06-10450.00M shares
10-Q · filed 2026-08-10
2026-03-31300.00M shares
10-Q · filed 2026-05-12
2025-12-31300.00M shares
10-Q · filed 2026-08-10
2025-12-03300.00M shares
10-K · filed 2026-03-20
2025-09-30280.00M shares
10-Q · filed 2025-11-10
2025-06-30280.00M shares
10-Q · filed 2025-08-11
2025-03-31280.00M shares
10-Q · filed 2025-05-12
2024-12-31280.00M shares
10-K · filed 2026-03-20
2024-09-30280.00M shares
10-Q · filed 2024-11-12
2024-06-30280.00M shares
10-Q · filed 2024-08-12
2024-03-31280.00M shares
10-Q · filed 2024-05-13
2023-12-31280.00M shares
10-K · filed 2025-03-24
2023-09-30280.00M shares
10-Q · filed 2023-11-09
2023-06-30280.00M shares
10-Q · filed 2023-08-10
2023-03-31280.00M shares
10-Q · filed 2023-05-11
2022-12-31280.00M shares
10-K · filed 2024-03-26
2022-10-06280.00M shares
10-K · filed 2023-03-22
2022-09-30300.00M shares
10-Q · filed 2022-11-14
2022-06-30300.00M shares
10-Q · filed 2022-08-15
2022-03-31300.00M shares
10-Q · filed 2022-05-13
2021-12-31300.00M shares
10-K · filed 2023-03-22
2021-09-30300.00M shares
10-Q · filed 2021-11-12
2021-06-30300.00M shares
10-Q · filed 2021-08-23
2021-03-31300.00M shares
10-Q · filed 2021-05-14
2020-12-316.80M shares
10-K · filed 2022-03-17
300.00M shares
10-K · filed 2021-03-22
2020-09-30300.00M shares
10-Q · filed 2020-11-10
2020-06-30300.00M shares
10-Q · filed 2020-08-13
2020-03-31300.00M shares
10-Q · filed 2020-05-15
2019-12-31300.00M shares
10-K · filed 2021-03-22
2019-09-30300.00M shares
10-Q · filed 2019-11-14
2019-06-30300.00M shares
10-Q · filed 2019-08-14
2019-03-31300.00M shares
10-Q · filed 2019-05-14
2018-12-31300.00M shares
10-K · filed 2020-03-27
2018-09-30300.00M shares
10-Q · filed 2018-11-14
2018-06-30300.00M shares
10-Q · filed 2018-08-13
2018-03-31300.00M shares
10-Q · filed 2018-05-15
2017-12-31300.00M shares
10-K · filed 2019-03-22
2017-09-30300.00M shares
10-Q · filed 2017-11-08
2017-06-30300.00M shares
10-Q · filed 2017-08-08
2017-03-31300.00M shares
10-Q · filed 2017-05-10
2016-12-31300.00M shares
10-K · filed 2018-04-02
2016-09-30300.00M shares
10-Q · filed 2016-11-08
2016-06-30300.00M shares
10-Q · filed 2016-08-11
2016-03-31300.00M shares
10-Q · filed 2016-05-09
2015-12-31300.00M shares
10-K · filed 2017-03-23
2015-09-30300.00M shares
10-Q · filed 2015-11-09
2015-06-30300.00M shares
10-Q · filed 2015-08-10
2015-03-31300.00M shares
10-Q · filed 2015-05-08
2014-12-31300.00M shares
10-K · filed 2016-03-14
2014-09-30300.00M shares
10-Q · filed 2014-11-07
2014-06-30300.00M shares
10-Q · filed 2014-11-07
2014-03-31150.00M shares
10-Q · filed 2014-05-12
2013-12-31300.00M shares
10-K · filed 2015-03-16
150.00M shares
10-K · filed 2014-03-10
2013-09-30150.00M shares
10-Q · filed 2013-11-12
2013-06-30150.00M shares
10-Q · filed 2013-08-08
2013-03-31150.00M shares
10-Q · filed 2013-05-10
2012-12-31150.00M shares
10-K · filed 2014-03-10
2012-09-30150.00M shares
10-Q · filed 2012-11-09
2012-06-30150.00M shares
10-Q · filed 2012-08-09
2012-03-31150.00M shares
10-Q · filed 2012-05-09
2011-12-31150.00M shares
10-K · filed 2013-03-15
2011-09-30150.00M shares
10-Q · filed 2011-11-09
2011-06-30150.00M shares
10-Q/A · filed 2011-09-23
2010-12-31150.00M shares
10-K · filed 2012-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Lexeo Therapeutics, Inc. (LXEO)United States$0.278B-4.19
FATE THERAPEUTICS INC (FATE)United States$0.280B-2.51
Invivyd, Inc. (IVVD)United States$0.270B-2.42
Liminatus Pharma, Inc. (LIMN)United States$0.282B
SUTRO BIOPHARMA, INC. (STRO)United States$0.260B-3.05
Inhibikase Therapeutics, Inc. (IKT)United States$0.296B-4.44
X4 Pharmaceuticals, Inc (XFOR)United States$0.297B-4.99
SAB Biotherapeutics, Inc. (SABS)United States$0.306B-25.49
Century Therapeutics, Inc. (IPSC)United States$0.306B-4.02
Lineage Cell Therapeutics, Inc. (LCTX)United States$0.241B-10.35